Stocks / HSIC
HSIC stock forecast
HENRY SCHEIN INC · Healthcare · Medical Distribution
The model's rating
Outperform
HSIC is rated Outperform as of September 29, 2026: its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth.
Create a free account to compare any two stocks; the numeric score is part of Premium.
HSIC is not among the 20 largest holdings published for 2026 Q4. See the portfolio
HSIC against the S&P 500
| Period | HSIC | S&P 500 (SPY) |
|---|---|---|
| 1 month | -6.5% | -0.3% |
| 3 months | -0.7% | +2.5% |
| Year to date | +11.1% | +12.7% |
| 1 year | +26.5% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $83.97 |
| Market cap | 9.36 Billion |
| P/E (trailing 12 months) | 24.3 |
| P/S (trailing 12 months) | 0.7 |
| P/B (latest quarter) | 3.1 |
| Gross margin | 31.3% |
| Net profit margin | 3.0% |
| Return on equity | 12.4% |
| Beta | 0.5 |
As of August 4, 2026.
HSIC and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| CAH | CARDINAL HEALTH INC | 51.75 Billion | Greatly Outperform | CAH vs HSIC |
| COR | CENCORA INC | 57.3 Billion | Outperform | COR vs HSIC |
| MCK | MCKESSON CORP | 99.55 Billion | Greatly Outperform | MCK vs HSIC |
Questions
What does the Upfront Investment model say about HSIC?
The model rates HENRY SCHEIN INC (HSIC) "Outperform" as of September 29, 2026, which means its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the HSIC rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is HSIC in the Upfront Investment model portfolio?
HSIC is not among the 20 largest holdings published for 2026 Q4.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.